RenoDiet-HP in Chronic Kidney Disease Patients Undergoing Maintenance Hemodialysis
- Conditions
- Health Condition 1: N189- Chronic kidney disease, unspecified
- Registration Number
- CTRI/2020/12/030086
- Lead Sponsor
- Pulse Pharmaceuticals Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. All consenting patients with CKD, above 18 years of age, and receiving twice or thrice weekly maintenance hemodialysis for atleast 6 months at the outpatient hemodialysis unit will be included in the study.
2. Patients willing to sign the Informed Consent Form (ICF).
1. Patients with intercurrent acute illnesses.
2. Bodyweight less than 40 kg.
3. Documented history of dialysis non-compliance.
4. Documented malabsorption syndrome.
5. Contraindications to any ingredient of RenoDiet-HP.
6. Chronic illness that, in the opinion of the investigator, is at a stage where it might interfere with trial conduct or completion. (Chronic illness may include but is not limited to, cardiac, renal, autoimmune, hepatic, haematological, genetic disorders, atopic conditions, congenital defects, diabetes, convulsions or encephalopathy, tuberculosis etc.).
7. Pregnant & Lactating women.
8. Patients who are not willing to sign the ICF.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method